Leonard Frank X, CEO of NovoCure Ltd ($NVCR), made six open market sales of company shares over the past year, totaling $834 thousand. His most recent sale occurred on March 4, 2026. Among nearly 12,000 insiders with recent sales, his activity ranks 5,340th by total value, well below the average of $8.6 million and 6.4 transactions per insider. He reported no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 3, 2026 | NovoCure Ltd | $NVCR | Leonard Frank X | Chief Executive Officer | A | Stock Option (Right to Buy) | 216388 | $0.00 | 216,388.0000 | 111,981,981 | 9999.99% | 0.19% |
| March 3, 2026 | NovoCure Ltd | $NVCR | Leonard Frank X | Chief Executive Officer | A | Ordinary Shares | 150000 | $0.00 | 499,400.0000 | 111,981,981 | 42.93% | 0.13% |
| March 4, 2026 | NovoCure Ltd | $NVCR | Leonard Frank X | Chief Executive Officer | S | Ordinary Shares | 5607 | $13.31 | 493,793.0000 | 111,981,981 | 1.12% | 0.01% |
| Feb. 27, 2026 | NovoCure Ltd | $NVCR | Leonard Frank X | Chief Executive Officer | S | Ordinary Shares | 9734 | $13.66 | 338,011.0000 | 111,981,981 | 2.80% | 0.01% |
| Feb. 28, 2026 | NovoCure Ltd | $NVCR | Leonard Frank X | Chief Executive Officer | A | Ordinary Shares | 18621 | $0.00 | 356,632.0000 | 111,981,981 | 5.51% | 0.02% |
| March 2, 2026 | NovoCure Ltd | $NVCR | Leonard Frank X | Chief Executive Officer | S | Ordinary Shares | 7232 | $13.49 | 349,400.0000 | 111,981,981 | 2.03% | 0.01% |
| Nov. 1, 2025 | NovoCure Ltd | $NVCR | Leonard Frank X | EVP, Pres., Novocure Oncology | F | Ordinary Shares | 966 | $12.81 | 347,745.0000 | 111,981,981 | 0.28% | 0.00% |
| June 30, 2025 | NovoCure Ltd | $NVCR | Leonard Frank X | EVP, Pres., Novocure Oncology | A | Ordinary Shares | 833 | $15.13 | 348,711.0000 | 109,915,429 | 0.24% | 0.00% |
| June 4, 2025 | NovoCure Ltd | $NVCR | Leonard Frank X | EVP, Pres., Novocure Oncology | A | Ordinary Shares | 179426 | $0.00 | 347,878.0000 | 109,915,429 | 106.51% | 0.16% |
| June 2, 2025 | NovoCure Ltd | $NVCR | Leonard Frank X | EVP, Pres., Novocure Oncology | S | Ordinary Shares | 1879 | $19.01 | 168,452.0000 | 109,915,429 | 1.10% | 0.00% |
| June 2, 2025 | NovoCure Ltd | $NVCR | Leonard Frank X | EVP, Pres., Novocure Oncology | S | Ordinary Shares | 6600 | $17.99 | 170,331.0000 | 109,915,429 | 3.73% | 0.01% |
| June 2, 2025 | NovoCure Ltd | $NVCR | Leonard Frank X | EVP, Pres., Novocure Oncology | S | Ordinary Shares | 21717 | $17.22 | 176,931.0000 | 109,915,429 | 10.93% | 0.02% |
| March 4, 2025 | NovoCure Ltd | $NVCR | Leonard Frank X | EVP, Pres., Novocure Oncology | A | Stock Options (Right to buy) | 81499 | $18.19 | 81,499.0000 | 109,915,429 | 9999.99% | 0.07% |
| March 4, 2025 | NovoCure Ltd | $NVCR | Leonard Frank X | EVP, Pres., Novocure Oncology | A | Ordinary Shares | 54975 | $18.19 | 198,648.0000 | 109,915,429 | 38.26% | 0.05% |
| March 3, 2025 | NovoCure Ltd | $NVCR | Leonard Frank X | EVP, Pres., Novocure Oncology | S | Ordinary Shares | 2527 | $18.54 | 143,673.0000 | 109,915,429 | 1.73% | 0.00% |
| Feb. 28, 2025 | NovoCure Ltd | $NVCR | Leonard Frank X | EVP, Pres., Novocure Oncology | S | Ordinary Shares | 2770 | $18.28 | 146,200.0000 | 109,915,429 | 1.86% | 0.00% |
| Feb. 27, 2025 | NovoCure Ltd | $NVCR | Leonard Frank X | EVP, Pres., Novocure Oncology | S | Ordinary Shares | 10277 | $19.92 | 150,959.0000 | 109,915,429 | 6.37% | 0.01% |
| Feb. 27, 2025 | NovoCure Ltd | $NVCR | Leonard Frank X | EVP, Pres., Novocure Oncology | S | Ordinary Shares | 1989 | $20.55 | 148,970.0000 | 109,915,429 | 1.32% | 0.00% |
| Feb. 28, 2025 | NovoCure Ltd | $NVCR | Leonard Frank X | EVP, Pres., Novocure Oncology | S | Ordinary Shares | 2770 | $18.28 | 146,200.0000 | 109,915,429 | 1.86% | 0.00% |
| Feb. 27, 2025 | NovoCure Ltd | $NVCR | Leonard Frank X | EVP, Pres., Novocure Oncology | S | Ordinary Shares | 10277 | $19.92 | 150,959.0000 | 109,915,429 | 6.37% | 0.01% |
| Feb. 27, 2025 | NovoCure Ltd | $NVCR | Leonard Frank X | EVP, Pres., Novocure Oncology | S | Ordinary Shares | 1989 | $20.55 | 148,970.0000 | 109,915,429 | 1.32% | 0.00% |
| Nov. 1, 2024 | NovoCure Ltd | $NVCR | Leonard Frank X | EVP, Pres., Novocure Oncology | S | Ordinary Shares | 598 | $15.94 | 161,236.0000 | 0 | 0.37% | 0.00% |
| June 28, 2024 | NovoCure Ltd | $NVCR | Leonard Frank X | EVP, Pres., Novocure Oncology | A | Ordinary Shares | 1736 | $12.24 | 161,834.0000 | 0 | 1.08% | 0.00% |
| March 4, 2024 | NovoCure Ltd | $NVCR | Leonard Frank X | EVP, Pres., Novocure Oncology | S | Ordinary Shares | 840 | $16.01 | 160,098.0000 | 0 | 0.52% | 0.00% |
| March 1, 2024 | NovoCure Ltd | $NVCR | Leonard Frank X | EVP, Pres., Novocure Oncology | S | Ordinary Shares | 1679 | $16.03 | 160,938.0000 | 0 | 1.03% | 0.00% |
| Feb. 28, 2024 | NovoCure Ltd | $NVCR | Leonard Frank X | EVP, Pres., Novocure Oncology | S | Ordinary Shares | 2078 | $16.14 | 162,617.0000 | 0 | 1.26% | 0.00% |
| Feb. 27, 2024 | NovoCure Ltd | $NVCR | Leonard Frank X | EVP, Pres., Novocure Oncology | A | Stock Options (Right to buy) | 156348 | $16.30 | 156,348.0000 | 0 | 9999.99% | 0.00% |
| Feb. 27, 2024 | NovoCure Ltd | $NVCR | Leonard Frank X | EVP, Pres., Novocure Oncology | A | Ordinary Shares | 102249 | $16.30 | 164,695.0000 | 0 | 163.74% | 0.00% |
| March 3, 2023 | NovoCure Ltd | $NVCR | Leonard Frank X | President, CNS Cancers US | S | Ordinary Shares | 888 | $76.16 | 62,602.0000 | 0 | 1.40% | 0.00% |
| March 7, 2023 | NovoCure Ltd | $NVCR | Leonard Frank X | President, CNS Cancers US | S | Ordinary Shares | 6003 | $75.00 | 56,599.0000 | 0 | 9.59% | 0.00% |
| March 7, 2023 | NovoCure Ltd | $NVCR | Leonard Frank X | President, CNS Cancers US | S | Ordinary Shares | 2315 | $75.59 | 54,284.0000 | 0 | 4.09% | 0.00% |
| March 3, 2023 | NovoCure Ltd | $NVCR | Leonard Frank X | President, CNS Cancers US | S | Ordinary Shares | 4403 | $76.16 | 63,490.0000 | 0 | 6.49% | 0.00% |
| March 3, 2023 | NovoCure Ltd | $NVCR | Leonard Frank X | President, CNS Cancers US | A | Ordinary Shares | 11808 | $0.00 | 69,952.0000 | 0 | 20.31% | 0.00% |
| March 3, 2023 | NovoCure Ltd | $NVCR | Leonard Frank X | President, CNS Cancers US | S | Ordinary Shares | 2059 | $77.64 | 67,893.0000 | 0 | 2.94% | 0.00% |
| March 2, 2023 | NovoCure Ltd | $NVCR | Leonard Frank X | President, CNS Cancers US | S | Ordinary Shares | 844 | $75.28 | 58,144.0000 | 0 | 1.43% | 0.00% |
| March 2, 2023 | NovoCure Ltd | $NVCR | Leonard Frank X | President, CNS Cancers US | S | Ordinary Shares | 308 | $76.05 | 58,988.0000 | 0 | 0.52% | 0.00% |
| March 2, 2023 | NovoCure Ltd | $NVCR | Leonard Frank X | President, CNS Cancers US | S | Ordinary Shares | 3799 | $75.32 | 59,296.0000 | 0 | 6.02% | 0.00% |
| March 1, 2023 | NovoCure Ltd | $NVCR | Leonard Frank X | President, CNS Cancers US | S | Ordinary Shares | 1684 | $76.36 | 63,095.0000 | 0 | 2.60% | 0.00% |
| Feb. 28, 2023 | NovoCure Ltd | $NVCR | Leonard Frank X | President, CNS Cancers US | A | Ordinary Shares | 18621 | $0.00 | 64,779.0000 | 0 | 40.34% | 0.00% |
| Feb. 28, 2023 | NovoCure Ltd | $NVCR | Leonard Frank X | President, CNS Cancers US | A | Options to Buy Ordinary Shares | 30971 | $76.97 | 30,971.0000 | 0 | 9999.99% | 0.00% |
| Jan. 5, 2023 | NovoCure Ltd | $NVCR | Leonard Frank X | President, CNS Cancers US | M | Ordinary Shares | 7183 | $21.15 | 53,341.0000 | 0 | 15.56% | 0.00% |
| Jan. 5, 2023 | NovoCure Ltd | $NVCR | Leonard Frank X | President, CNS Cancers US | S | Ordinary Shares | 7183 | $120.00 | 46,158.0000 | 0 | 13.47% | 0.00% |
| Jan. 5, 2023 | NovoCure Ltd | $NVCR | Leonard Frank X | President, CNS Cancers US | M | Options to Buy Ordinary Shares | 7826 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Jan. 5, 2023 | NovoCure Ltd | $NVCR | Leonard Frank X | President, CNS Cancers US | M | Options to Buy Ordinary Shares | 7500 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Jan. 5, 2023 | NovoCure Ltd | $NVCR | Leonard Frank X | President, CNS Cancers US | M | Options to Buy Ordinary Shares | 5517 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Jan. 5, 2023 | NovoCure Ltd | $NVCR | Leonard Frank X | President, CNS Cancers US | M | Options to Buy Ordinary Shares | 7183 | $0.00 | 10,479.0000 | 0 | 40.67% | 0.00% |
| Jan. 5, 2023 | NovoCure Ltd | $NVCR | Leonard Frank X | President, CNS Cancers US | M | Options to Buy Ordinary Shares | 7183 | $0.00 | 17,662.0000 | 0 | 28.91% | 0.00% |
| Jan. 5, 2023 | NovoCure Ltd | $NVCR | Leonard Frank X | President, CNS Cancers US | S | Ordinary Shares | 7826 | $108.00 | 46,158.0000 | 0 | 14.50% | 0.00% |
| Jan. 5, 2023 | NovoCure Ltd | $NVCR | Leonard Frank X | President, CNS Cancers US | M | Ordinary Shares | 7826 | $14.37 | 53,984.0000 | 0 | 16.95% | 0.00% |
| Jan. 5, 2023 | NovoCure Ltd | $NVCR | Leonard Frank X | President, CNS Cancers US | S | Ordinary Shares | 1010 | $117.00 | 46,158.0000 | 0 | 2.14% | 0.00% |
| Jan. 5, 2023 | NovoCure Ltd | $NVCR | Leonard Frank X | President, CNS Cancers US | S | Ordinary Shares | 526 | $115.03 | 47,168.0000 | 0 | 1.10% | 0.00% |
| Jan. 5, 2023 | NovoCure Ltd | $NVCR | Leonard Frank X | President, CNS Cancers US | S | Ordinary Shares | 417 | $108.00 | 47,694.0000 | 0 | 0.87% | 0.00% |
| Jan. 5, 2023 | NovoCure Ltd | $NVCR | Leonard Frank X | President, CNS Cancers US | S | Ordinary Shares | 2345 | $119.01 | 48,111.0000 | 0 | 4.65% | 0.00% |
| Jan. 5, 2023 | NovoCure Ltd | $NVCR | Leonard Frank X | President, CNS Cancers US | S | Ordinary Shares | 7500 | $108.00 | 46,158.0000 | 0 | 13.98% | 0.00% |
| Jan. 5, 2023 | NovoCure Ltd | $NVCR | Leonard Frank X | President, CNS Cancers US | M | Ordinary Shares | 7500 | $11.46 | 53,658.0000 | 0 | 16.25% | 0.00% |
| Jan. 5, 2023 | NovoCure Ltd | $NVCR | Leonard Frank X | President, CNS Cancers US | M | Ordinary Shares | 5517 | $7.15 | 51,675.0000 | 0 | 11.95% | 0.00% |
| Jan. 5, 2023 | NovoCure Ltd | $NVCR | Leonard Frank X | President, CNS Cancers US | S | Ordinary Shares | 5517 | $108.00 | 46,158.0000 | 0 | 10.68% | 0.00% |
| Jan. 5, 2023 | NovoCure Ltd | $NVCR | Leonard Frank X | President, CNS Cancers US | M | Ordinary Shares | 7183 | $21.15 | 53,341.0000 | 0 | 15.56% | 0.00% |
| Jan. 5, 2023 | NovoCure Ltd | $NVCR | Leonard Frank X | President, CNS Cancers US | S | Ordinary Shares | 7183 | $114.00 | 46,158.0000 | 0 | 13.47% | 0.00% |